Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Whitlow and Ralph D'Agostino.
Connection Strength
0.329
-
Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Agostino RJ, Lycan T, Farris MK, Ververs J, Lo HW, Watabe K, Topaloglu U, Li W, Whitlow C, Su J, Wang G, Chan MD, Xing F, Ruiz J. Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases. Front Oncol. 2023; 13:1214126.
Score: 0.113
-
Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland DJ, Chan MD, Thomas A, Barbault A, D'Agostino RB, Whitlow CT, Kirchner V, Blackman C, Pasche B, Watabe K. Corrigendum to-"Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF"-[eBiomedicine, 44 (2019) 194-208]. EBioMedicine. 2025 Jan; 111:105541.
Score: 0.061
-
Choi AR, D'Agostino RB, Farris MK, Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Ruiz J, Lycan TW, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Li W, Su J, Whitlow C, Xing F, Chan MD. Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne). 2024; 15:1364021.
Score: 0.060
-
Abdulhaleem M, Johnston H, D'Agostino R, Lanier C, Cramer CK, Triozzi P, Lo HW, Xing F, Li W, Whitlow C, White JJ, Tatter SB, Laxton AW, Su J, Chan MD, Ruiz J. Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases. Neurosurg Pract. 2023 Mar; 4(1):e00026.
Score: 0.053
-
Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland JD, Chan MD, Thomas A, Barbault A, D'Agostino RB, Whitlow CT, Kirchner V, Blackman C, Pasche B, Watabe K. Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF. EBioMedicine. 2019 Jun; 44:194-208.
Score: 0.042